Androgen receptor decoy molecules block the growth of prostate cancer
about
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysisMolecular signaling involving intrinsically disordered proteins in prostate cancerA sting in the tail: the N-terminal domain of the androgen receptor as a drug targetCharacterization of niphatenones that inhibit androgen receptor N-terminal domainSmall molecule inhibitors targeting the "achilles' heel" of androgen receptor activityIntrinsic disorder in the androgen receptor: identification, characterisation and drugability.Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer.Androgen receptor and its splice variants in prostate cancerNoncanonical mechanisms to regulate nuclear receptor signaling.Evolving Personalized Therapy for Castration-Resistant Prostate Cancer.Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.Androgen receptor: structure, role in prostate cancer and drug discovery.Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate CancerAn androgen receptor N-terminal domain antagonist for treating prostate cancer.Experimental evidence of persistent androgen-receptor-dependency in castration-resistant prostate cancer.Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.Pleiotropic functional properties of androgen receptor mutants in prostate cancer.Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer.Beyond castration-defining future directions in the hormonal treatment of prostate cancer.Androgen receptor antagonists: a patent review (2008-2011).Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer.Androgen receptor modulators: a marriage of chemistry and biology.New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer.Androgen receptor-related diseases: what do we know?Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.A genetic reporter system to gauge cell proliferation rate.Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.Down-regulation of androgen-receptor and PSA by phytochemicals.Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor.Perspectives on designs of antiandrogens for prostate cancer.Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.Reliability of a composite measure of social inclusion for people with psychiatric disabilities.
P2860
Q24301596-9D41153B-B3A3-46ED-8B84-EF837DDEC00EQ26747089-625DC81E-FB4E-4AAB-B13E-134D18B0BDA5Q26747094-4E0FF762-05FB-406C-B347-89FC673928D7Q28543404-5935D5D2-D0BE-4894-BE88-4FB185B358ACQ33810134-4AFE043F-AF91-4C8F-8E9F-D65D842852D0Q33984776-8B198FF2-DB20-4563-9DBA-18F076C7A6BCQ33990433-69A4AF8E-17AA-475D-8A11-83F8CFE33C78Q34199684-C22C93CE-8CBB-446C-B2BB-523BC34515EAQ34338685-46770D4C-2CD4-4672-B7A6-43DEEA3966D2Q34691562-59E9F61D-5252-4C57-B211-1329594CCE93Q35001285-D3C290B3-7F1F-40BA-ACE2-A31A94B54A3FQ36063723-AA189264-AFD4-4A19-ACA7-6F4D856A09E1Q36312095-2A5EBD7D-A8F5-449C-BB8B-7F9F6D70E2C9Q36963697-987A13AA-BE66-4218-984D-362045E7D45DQ36966859-18F0D287-DCE5-4FE4-9C61-0E1E510B2C70Q37139070-1F2E93B3-3504-4BCF-9FEE-68C36C38E6ACQ37145531-E9A4CD3D-663C-4323-9CBF-0F28E5194483Q37272639-6DBAFD16-A48D-46E7-8947-2FDCC18A897EQ37564765-2FE8FC3D-31AC-4EB1-A0EB-BE304C1B1C54Q37962393-DAC70E1A-5CE5-492D-BAC5-6F77604D27BAQ38009888-65C4AD44-7E11-465C-B719-3B9AAE835188Q38076345-2CA0C486-30A8-4059-8A07-8D091749A246Q38114780-92608A29-FEB8-46AB-8DB5-4BF595B093B6Q38116575-140ACDBF-F92B-4FEA-B456-01638A86A3EAQ38745981-6A639D71-8E85-4F96-92E2-FE5B43072549Q38780007-3B4E83B3-F140-4A94-BC08-998C2B653450Q39220247-0FBC4279-489C-4359-8C86-43DB6567869CQ39558406-5710D673-4923-4768-A6B8-4B19DC1BA613Q39967217-6E94895E-A589-4E0B-A71F-1D9CF2788E74Q40023730-006DAC9E-35B8-496E-B8B9-A3B1B63C95CDQ40293980-3998878F-4914-4D0F-8660-344FD4A6A009Q41115283-0A49627C-917A-430C-9B6E-638F83C08BE3Q46635646-A8A39D13-5BD0-45D8-A5B6-8D00EF174F6FQ47307286-4DE5657B-BEDA-4792-A44F-B6619E8B7E58Q50455684-69CDF9E7-3BF3-4C15-9A76-C594B2594708Q51893327-58692D90-5AEE-417C-992A-DD4AC4A89ACC
P2860
Androgen receptor decoy molecules block the growth of prostate cancer
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Androgen receptor decoy molecules block the growth of prostate cancer
@ast
Androgen receptor decoy molecules block the growth of prostate cancer
@en
type
label
Androgen receptor decoy molecules block the growth of prostate cancer
@ast
Androgen receptor decoy molecules block the growth of prostate cancer
@en
prefLabel
Androgen receptor decoy molecules block the growth of prostate cancer
@ast
Androgen receptor decoy molecules block the growth of prostate cancer
@en
P2093
P2860
P356
P1476
Androgen receptor decoy molecules block the growth of prostate cancer
@en
P2093
Nasrin R Mawji
Steven N Quayle
P2860
P304
P356
10.1073/PNAS.0606718104
P407
P50
P577
2007-01-16T00:00:00Z